Mary Fidler to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications Mary Fidler has written about Antineoplastic Agents, Immunological.
Connection Strength
0.328
-
Relationship between circulating tumor-associated autoantibodies and clinical outcomes in advanced-stage NSCLC patients receiving PD-1/-L1 directed immune checkpoint inhibition. J Immunol Methods. 2021 03; 490:112956.
Score: 0.178
-
Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC). J Thorac Oncol. 2018 09; 13(9):1393-1399.
Score: 0.150